Belpointe Asset Management LLC acquired a new position in shares of Amdocs Limited (NASDAQ:DOX - Free Report) during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund acquired 10,737 shares of the technology company's stock, valued at approximately $982,000.
Other institutional investors also recently modified their holdings of the company. OneDigital Investment Advisors LLC increased its stake in shares of Amdocs by 20.8% during the 1st quarter. OneDigital Investment Advisors LLC now owns 3,026 shares of the technology company's stock worth $277,000 after purchasing an additional 521 shares during the last quarter. Farther Finance Advisors LLC increased its stake in shares of Amdocs by 17.5% during the 1st quarter. Farther Finance Advisors LLC now owns 988 shares of the technology company's stock worth $90,000 after purchasing an additional 147 shares during the last quarter. Cambridge Investment Research Advisors Inc. increased its stake in shares of Amdocs by 7.8% during the 1st quarter. Cambridge Investment Research Advisors Inc. now owns 6,738 shares of the technology company's stock worth $616,000 after purchasing an additional 490 shares during the last quarter. Ritholtz Wealth Management boosted its holdings in shares of Amdocs by 18.9% during the 1st quarter. Ritholtz Wealth Management now owns 3,195 shares of the technology company's stock worth $292,000 after buying an additional 507 shares during the period. Finally, Norden Group LLC boosted its holdings in shares of Amdocs by 26.9% during the 1st quarter. Norden Group LLC now owns 3,978 shares of the technology company's stock worth $364,000 after buying an additional 843 shares during the period. 92.02% of the stock is currently owned by institutional investors and hedge funds.
Analyst Ratings Changes
Several analysts recently commented on DOX shares. Wolfe Research started coverage on shares of Amdocs in a report on Tuesday, July 8th. They set an "outperform" rating for the company. Wall Street Zen raised shares of Amdocs from a "hold" rating to a "buy" rating in a report on Sunday, August 10th. Four equities research analysts have rated the stock with a Buy rating, According to MarketBeat.com, Amdocs has a consensus rating of "Buy" and a consensus target price of $105.33.
Read Our Latest Research Report on Amdocs
Amdocs Price Performance
Shares of Amdocs stock opened at $85.33 on Friday. Amdocs Limited has a twelve month low of $78.61 and a twelve month high of $95.41. The company has a quick ratio of 1.22, a current ratio of 1.22 and a debt-to-equity ratio of 0.23. The company has a 50-day simple moving average of $87.33 and a two-hundred day simple moving average of $88.56. The stock has a market capitalization of $9.63 billion, a price-to-earnings ratio of 17.31, a price-to-earnings-growth ratio of 1.53 and a beta of 0.54.
Amdocs (NASDAQ:DOX - Get Free Report) last issued its quarterly earnings data on Wednesday, August 6th. The technology company reported $1.72 earnings per share for the quarter, topping the consensus estimate of $1.71 by $0.01. Amdocs had a net margin of 11.94% and a return on equity of 19.66%. The business had revenue of $1.14 billion during the quarter, compared to analysts' expectations of $1.13 billion. During the same quarter in the previous year, the company earned $1.62 EPS. The business's revenue was down 8.4% on a year-over-year basis. Analysts forecast that Amdocs Limited will post 6.21 EPS for the current year.
Amdocs Announces Dividend
The company also recently announced a quarterly dividend, which will be paid on Friday, October 31st. Stockholders of record on Tuesday, September 30th will be given a $0.527 dividend. The ex-dividend date is Tuesday, September 30th. This represents a $2.11 annualized dividend and a dividend yield of 2.5%. Amdocs's payout ratio is presently 42.60%.
Amdocs Profile
(
Free Report)
Amdocs Limited, through its subsidiaries, provides software and services worldwide. It designs, develops, operates, implements, supports, and markets open and modular cloud portfolio. The company provides CES23, a 5G and cloud-native microservices-based market-leading customer experience suite, that enables service providers to build, deliver, and monetize advanced services; Amdocs Subscription Marketplace, a software-as-a-service-based platform that includes an expansive network of pre-integrated digital services, such as media, gaming, eLearning, sports, and retail to security and business services; the monetization suite for charging, billing, policy, and revenue management; Intelligent networking suite with a set of modular, flexible, and open service lifecycle management capabilities for network automation journeys; amAIz, a telco GenAI framework; Amdocs Digital Brands Suite, a pre-integrated digital business suite; and Amdocs eSIM Cloud for service providers.
Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Amdocs, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Amdocs wasn't on the list.
While Amdocs currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.